Jpmorgan Chase & CO Bristol Myers Squibb CO Cont V Transaction History

Jpmorgan Chase & CO

  • $1.51 Trillion
  • Q3 2025

A detailed history of Jpmorgan Chase & CO transactions in Bristol Myers Squibb CO Cont V stock. As of the latest transaction made, Jpmorgan Chase & CO holds 23 shares of CELGRT stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23
Previous 23 -0.0%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024
BUY
N/A
23 New
23 $0

Others Institutions Holding CELGRT

# of Institutions
23
Shares Held
1.22M
Call Options Held
0
Put Options Held
0
View Full List

About BRISTOL MYERS SQUIBB CO CONT V

CELGRT Quotes by TradingView
  • Ticker CELGRT
More about CELGRT
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email